HEMOLY L TIC AN A EMIA

Similar documents
Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

3 Ruba hussein Dr. ahmad Dr. ahmad

Diagnostic Approach to Patients with Anemia

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Immunohematology (Introduction)

Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition

TRANSFUSION REACTIONS

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

HEMOLYTIC ANEMIA Anemia of increased destruction Normochromic, normochromic anemia Shortened RBC survival Reticulocytosis - Response to increased RBC

9/23/2018. Investigation of Hemolysis in the Clinical Laboratory. Objectives. What is hemolysis?

General Characterisctics

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY

Brrrr, It s Cold In Here

Transfusion Reactions. Directed by M-azad March 2012

Hematology Unit Lab 1 Review Material

Hemolytic Anemia. Hemolytic Anemia Classification Intracorpuscular Defects. Hemolytic Anemia Classification

Introduction and Approach to Anemia

Immunohematology. Done by : Zaid Al-Ghnaneem

Dr. Shiva Nazari Assistant Professor of Pediatric Oncologist & Hematologist Shahid Beheshti Medical Science University Mofid Children s Hospital

New phase 2 Clinical Trial Enrolling Now

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

HAEMOLYTIC ANAEMIA. Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician

Approach to a pale child

New phase 2 Clinical Trial Enrolling Now

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Peripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Sysmex Educational Enhancement and Development No

Blood Cell Identification Graded

Non-immune acquired haemolytic anaemias. Dr.Maysem

The Lecture s topics

Immunological transfusion reactions

HEMATOPOIESIS. HEMATOLOGY Introduction. Study of blood & its components Window of rest of body. Introduction

AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

Year 2003 Paper two: Questions supplied by Tricia

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Approach to Hemolysis

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

TRANSFUSION REACTION EVALUATION

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Erythrocyte sedimentation rate. Hemolysis. Blood groups. Erythrocyte sedimentation rate (ESR)

Laboratory Techniques. Tehran Medical Branch Islamic Azad University

Glucose-6-Phosphate Dehydrogenase

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Hematologic changes in systemic diseases. Chittima Sirijerachai

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

The Child with a Hematologic Alteration

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager

Case Report A Case of WarmAutoimmune HaemolyticAnaemiaPresenting with Intravascular Haemolysis

PNH Glossary of Terms

Paroxysmal Nocturnal Hemoglobinuria

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

When Selfies Go Bad!

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital

- Ensherah Mokheemer. - Rama Nada. - Tareq Aladily. 1 P a g e

HEMOLYSIS AND JAUNDICE:

AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA); A HEMATOLOGIC PERSPECTIVE AT A TERTIARY CARE HOSPITAL.

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Red cell disorder. Dr. Ahmed Hasan

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Index. Note: Page numbers of article titles are in boldface type.

RBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

Non-Infectious Transfusion Reactions

Participants Identification No. % Evaluation. Spherocyte Educational Erythrocyte, normal Educational

The Evaluation and Classification of Anemia

Transfusion reactions illustrated

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Blood Transfusion Reactions

2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl)

Anemia In the Insurance Applicant What do the numbers mean?

Year 2004 Paper two: Questions supplied by Megan 1

CH 11 Blood OUTLINE: Functions of Blood Composition of Blood Blood Cell Disorders Blood Types Blood Clotting Functions of Blood Transportation

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

Hematology Revision. By Dr.AboRashad . Mob

Updates for your practice August 2013 TLALELETSO. HIV & Anemia. Continued on Page 2

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013

Done by :Aseel Twaijer & Laith Sorour Hemolytic Anemias

It should be noted that in the initial stage, nearly all anemias are normocytic. The major primary causes of normocytic anemia are given in Table 1.

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

HEMATOLOGY/ HEMATOPOIESIS

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

For more information about how to cite these materials visit

What are the four parts of blood and what are their main functions?

Hematology: Challenging Cases with Your Participation COPYRIGHT

Immune-Mediated Anemia

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.

Transcription:

HEMOLYTIC ANEMIA In a healthy person, a red blood cell survives 90 to 120 days in the circulation, so about 1% of human red blood cells break down each day. The spleen (part of the reticulo-endothelial system) is the main organ that removes old and damaged RBCs from the circulation. In healthy individuals, the breakdown and removal of RBCs from the circulation is matched by the production of new RBCs in the bone marrow. Extravascular hemolysis occurs when RBCs are phagocytized by macrophages in the spleen, liver and bone marrow. During the normal aging of red cells in the circulation, effete red cells are destroyed by macrophages, i.e. extravascular hemolysis is always occurring to some degree. However, this is a physiologic process and does not result in anemia or excessive unconjugated bilirubin production. (http://en.wikipedia.org/wiki/haematopoiesis) (http://www.nsbri.org/humanphysspace/focus3/erythropoiesis.html) (http://4drs.net/gallery/displayimage.php?album=1&pid=245#top_display_media) Hypoxia-inducible factor (HIF) - erythropoietin receptor (EpoR) - Erythropoietin, also known as erythropoetin or erthropoyetin or EPO Ref.: http://coppermine-gallery.net/

Hemolytic anemia (or haemolytic anaemia) is a form of anemia due to abnormal hemolysis, the excessivel breakdown of red blood cells (RBCs), either in the blood vessels (intravascular hemolysis) or elsewhere in the human body (extravascular). It has numerous possible causes, ranging from relatively harmless to life-threatening. Hemolytic anemias (intravascular or extravascular) are usually regenerative (if sufficient time is given for the marrow to regenerate and if there are no additional factors suppressing erythropoiesis). Diagnosis of the Hemolytic Anemia History and Physical Examination Anemia most often is discovered through laboratory tests, but the history and physical examination can provide important clues about the presence of hemolysis and its underlying cause. 1) The patient may complain of dyspnea or fatigue (caused by anemia). 2) Dark urine may be present 3) Occasionally, back pain may be reported by patients with intravascular hemolysis. 4) The skin may appear jaundiced or pale. 5) A resting tachycardia with a flow murmur may be present if the anemia is pronounced. 6) Lymphadenopathy or hepatosplenomegaly suggest an underlying lymphoproliferative disorder or malignancy 7) Alternatively, an enlarged spleen may reflect hypersplenism causing hemolysis. 8) Leg ulcers occur in some chronic hemolytic states, such as sickle cell anemia. Paraclinical Testing Workup: Standard blood studies for the workup of suspected hemolytic anemia include the following: 1. Complete blood cell count 2. Peripheral blood smear (PBS) 3. Serum lactate dehydrogenase (LDH) study 4. Serum haptoglobin 5. Indirect bilirubin In detail, the tests and the results are the: HEMATOLOGIC TESTS Along with anemia, a characteristic laboratory feature of hemolysis is reticulocytosis, the normal response of the bone marrow to the peripheral loss of red blood cells. In the absence of concomitant bone marrow disease, a brisk reticulocytosis should be observed within three to five days after a decline in hemoglobin. In a minority of patients, the bone marrow is able to chronically compensate, leading to a normal and stable hemoglobin concentration. The anemia of hemolysis usually is normocytic, although a marked reticulocytosis can lead to an elevated measurement of mean corpuscular volume, because the average mean corpuscular volume of a reticulocyte is 150 fl. Review of the peripheral blood smear is a critical step in the evaluation of any anemia. Along with an assessment for pathognomonic red blood cell morphologies, such as spherocytes or

schistocytes, examination of the white blood cells and platelets for coexisting hematologic or malignant disorders is essential. CHEMISTRY TESTS URINARY TESTS The destruction of red blood cells is characterized by 1) increased unconjugated bilirubin, 2) increased lactate dehydrogenase, 3) and decreased haptoglobin levels. Lactate dehydrogenase and hemoglobin are released into the circulation when red blood cells are destroyed. Liberated hemoglobin is converted into unconjugated bilirubin in the spleen or may be bound in the plasma by haptoglobin. The hemoglobin-haptoglobin complex is cleared quickly by the liver, leading to low or undetectable haptoglobin. In cases of severe intravascular hemolysis, the binding capacity of haptoglobin is exceeded rapidly, and free hemoglobin is filtered by the glomeruli. The renal tubule cells may absorb the hemoglobin and store the iron as hemosiderin; IMMUNOLOGIC TESTS 1) Hemosiderinuria is detected by Prussian blue staining of sloughed tubular cells in the urinary sediment approximately one week after the onset of hemolysis. 2) Hemoglobinuria, which causes red-brown urine, is indicated by a positive urine dipstick reaction for heme in the absence of red blood cells. The direct Coombs test (the direct antiglobulin test) is the hallmark of autoimmune hemolysis. Red blood cell agglutination with anti-igg serum reflects warm AIHA or warm agglutinins, while a positive anti-c3 DAT occurs with cold agglutinins; Warm AIHA also is associated with autoimmune diseases (e.g., systemic lupus erythematosus), while cold AIHA may occur following infections, particularly infectious mononucleosis and Mycoplasma pneumoniae infection. Human immunodeficiency virus infection can induce both warm and cold AIHA. Lymphoproliferative disorders (e.g., chronic lymphocytic leukemia, non-hodgkin s lymphoma) may produce warm or cold autoantibodies. A number of commonly prescribed drugs can induce production of both types of antibodies ( http://www.med.umich.edu/digitallab/m2pathlabs/hemepath/pdf%20files/2004%20concise%20review%20dx%20hemolytic%20anemia.pdf ) (reserve a l auteur: to access this text outside the Internet, just replace the title in the Address window) The general classification of hemolytic anemia takes in account either inherited or acquired.causes: A) Intrinsic causes 1) Hereditary (inherited) hemolytic anemia can be due to: a) Defects of red blood cell membrane production as in hereditary spherocytosis and hereditary elliptocytosis b) Hereditary (inherited) hemolytic anemia can be due to defects in hemoglobin : Defects in hemoglobin production as in thalassemia, sickle-cell disease a and congenital dyserythropoietic anemia c) Hereditary (inherited) hemolytic anemia can be due to enzyme defects: Defective red cell metabolism as in glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency 2) Acquired

a) Paroxysmal nocturnal hemoglobinuria (PNH), sometimes referred to as Marchiafava-Micheli syndrome, is a rare, acquired, potentially life-threatening disease of the blood characterized by complement-induced intravascular hemolytic anemia. Acute transfusion reactions may be divided into at least 8 distinct entities. Acute hemolytic transfusion reactions may be either immune mediated or non immune mediated. Immune-mediated hemolytic transfusion reactions caused by immunoglobulin M (IgM) anti-a, anti-b, or anti-a,b typically result in severe, potentially fatal complement-mediated intravascular hemolysis. Immune-mediated hemolytic reactions caused by immunoglobulin G (IgG), Rh, Kell, Kidd, or other non- ABO antibodies typically result in extravascular sequestration, shortened survival of transfused red cells, and relatively mild clinical reactions. Nonimmune hemolytic transfusion reactions occur when RBCs are damaged prior to transfusion, resulting in hemoglobinemia and hemoglobinuria without significant clinical symptoms. Nonhemolytic febrile transfusion reactions usually are caused by cytokines from leukocytes in transfused red cell or platelet components, causing significant clinical symptoms such as fever, chills, or rigors. B) Extrinsic causes Acquired hemolytic anemia may be caused by immune-mediated causes, drugs and other miscellaneous causes. a) Immune-mediated causes could include 1) transient factors as in Mycoplasma pneumoniae infection (cold agglutinin disease) 2) or permanent factors as in autoimmune diseases like autoimmune hemolytic anemia (itself more common in diseases such as systemic lupus erythematosus and chronic lymphocytic leukemia) a) Any of the causes of hypersplenism (increased activity of the spleen where the red blood cells iare normally destroyed) such as portal hypertension b) Acquired hemolytic anemia is also encountered in burns and as a result of certain infections. Bacterial contamination during blood transfusion and endotoxemia may result from inadequate sterile preparation of the phlebotomy site, opening the blood container in a nonsterile environment, or the presence of bacteria in the donor's circulation at the time of blood collection. c) Lead poisoning resulting from the environment causes non-immune hemolytic anemia. d) Runners can suffer hemolytic anemia due to "footstrike hemolysis", owing to the destruction of red blood cells in feet at foot impact. e) Low-grade hemolytic anemia occurs in 70% of prosthetic heart valve recipients, and severe hemolytic anemia occurs in 3% f) March hemoglobinuria Table of Classification of the Hemolytic Disorders Intrinsic Hereditary Acquired 1. as above as above 2. Rarer hereditary abnormalities Extrinsic 1. Physical agents: Burns, cold exposure 2. Chemical agents: Drugs and venoms 3. Infectious agents: Malaria,

toxoplasmosis, mononucleosis, hepatitis, primary atypical pneumonia, clostridial infections, bartonellosis, leishmaniasis 4. Traumatic: Prosthetic heart valves, march hemoglobinemia, DIC (disseminated intravascular coagulation), graft rejection 5. Diseases: Hepatic and renal disease Collagen vascular disease Malignancies: Particularly hematologic neoplasia 6. Immune-mediated causes Transfusion of incompatible blood Hemolytic disease of the newborn Cold hemagglutinin disease Autoimmune hemolytic anemia TTP (Thrombotic Thrombocytopenic Purpura) and HUS (hemolytic uremic syndrome) Chronic Intravascular Hemolysis occurs after Aortic Valve Replacement - Case Studies: To assess the severity of hemolysis and to determine whether severity of hemolysis was related to type of prosthesis, the following tests were performed at the New York Cornell University Hospital on 54 patients who had three different types of aortic ball-valve prostheses: 1. hematocrit readings (Hct), 2. schistocyte counts (S), 3. reticulocyte counts (R), 4. and determinations of haptoglobin (Hp), 5. lactic acid dehydrogenase (LDH), 6. bilirubin, 7. urinary hemoglobin, 8. and urinary hemosiderin (Hs). Results: They can be found at the online version located on the World Wide Web at: http://circ.ahajournals.org/content/44/4/657 Conclusion: At the end of the study, it ihas been concluded that hemolysis is more severe in the presence of Starr-Edwards valves than Magovern or Cutter valves.based on these observations, the following criteria for rapid clinical evaluation of cardiac hemolysis are suggested to determine the severity of hemolysis: 1. Mild: a) Hs (presence of urinary hemosiderin) b) or absence of Hp (haptoglobin) c) but S (schistocyte counts ) < 10, d) R (3. reticulocyte counts ) < 5, e) LDH < 500; 1. Moderate: a) Hs

b) or absence of Hp c) but S > 10, d) R > 5, e) LDH > 500; 1. Severe: all of above i.e., a) Hs b) or absence of Hp c) but S > 10, d) R > 5, e) LDH > 500; f) plus hemoglobinuria. Pathophysiology of anemia due heart valve prostehesis The red cell has a critical tolerance to shearing stress. High shearing stresses cause stretching of the membrane with tearing and cell fragmentation. Fragmented cells or schistocytes are not specific for heart valve hemolysis since fragmentation is an important final common pathway for red cell destruction in a variety of hemolytic states. However, the number of fragmented cells in the peripheral blood of patients with artificial heart valves appears to bear a direct relationship to the severity of the hemolysis. In the present study, schistocyte counts were significantly higher in patients without haptoglobins than in those with haptoglobins. Moreover, the magnitude of the counts correlated well with other measurements of red cell destruction such as reticulocyte counts, serum LDH and bilirubin (primarily unconjugated) determinations. Explanation of the variations in serum LDH levels: Since the red cell is rich in LDH fractions, hemolysis results in elevated serum levels, and increased concentrations of both total LDH and the isoenzyme LDH 1 have been reported in patients with aortic prostheses. In the present study elevation of total LDH was a constant finding, and good correlation was noted between LDH levels, schistocyte counts, reticulocyte counts, and serum bilirubin levels (table 1) a) The significantly higher levels found in the group without haptoglobins compared to the group with haptoglobins were due largely to more severe hemolysis in the former group. b) Extremely high values for LDH above 800 mu were seen only in those patients with hemoglobinuria. Explanation of the variations of serum haptoglobin: Red cell fragmentation results in loss of a piece of membrane which may or may not contain hemoglobin. a) Free hemoglobin dissociates into half molecules which are rapidly bound to plasma haptoglobin.' b) The hemoglobin-haptoglobin haptoglobin complex is too large to pass through the glomerulus and is cleared from the circulation by the reticuloendothelial system. Explanation of the hemoglobinuria and hemosiderunia: After plasma haptoglobin has been depleted, the half molecules (molecular weight, 34,000) pass through the glomerular filter into the proximal tubule, and the free hemoglobin remaining in the circulation is oxidized to methemoglobin. a) When large quantities of hemoglobin are presented to the tubule, the transport mechanism is exceeded and hemoglobinuria occurs. b) When smaller quantities are filtered, hemoglobin is absorbed by the cells of the proximal tubule where it is converted to ferritin and hemosiderin.

c) Later, when the tubule cells desquamate, hemosiderin granules may be seen by light microscopy in the sediment stained for iron. Thus hemoglobinuria occurs acutely with massive hemolysis while hemosiderinuria is found in chronic intravascular hemolysis. Since haptoglobin can be regenerated within several days following cessation of hemolysis while iron appears in the urine at a very slow rate, the simultaneous presence of haptoglobin and hemosiderin is probably indicative of intermittent rather than continuous hemolysis. In most reported cases of chronic intravascular 2' 26 hemolysis renal function has not been significantly impaired. Downloaded from http://circ.ahajournals.org/ by guest on December 20, 2012 EYSTER ET AL. 20 21 TREATMENT OF HEMOLYTIC ANEMIAS - LE TRAITEMENT DES ANEMIES HEMOLYTIQUES http://www.freewebs.com/rogerqualo/clini/traitementhemolyse.pdf Ref.: ELAINE EYSTER, JOHN ROTHCHILD and OLGA MYCHAJLIW; Chronic Intravascular Hemolysis after Aortic Valve Replacement : Long-Term Study Comparing Different Types of Ball-Valve Prostheses; Circulation. 1971;44:657-665; Copyright 1971 American Heart Association, Inc. All rights reserved S Gerald Sandler, MD, FACP, FCAP, and al.; Transfusion Reactions; emedicine Specialties > emedicine, Ob/Gyn, Psychiatry, and Surgery > Hematology; Last Updated: March 18, 2004 Paul Schick, MD and al.; Hemolytic Anemia Workup; Medscape Reference 2011 WebMD, LLC Hemolytic anemia; From Wikipedia, the free encyclopedia; last modified on 3 December 2012 at 23:52 Hemolytic Anemia GURPREET DHALIWAL, M.D., PATRICIA A. CORNETT, M.D., and LAWRENCE M. TIERNEY, JR., M.D., San Francisco Veterans Affairs Medical Center/University of California San Francisco School of Medicine, San Francisco, California